ask="4.000"
ask_size="700"
average_daily_volume="22176"
bid="2.930"
bid_size="500"
book_value="-0.228"
change="+0.122"
change_from_200_day_moving_average="-0.740"
change_from_50_day_moving_average="0.055"
change_from_52_week_high="-2.548"
change_From_52_week_low="1.138"
change_in_percent="+4.326%"
close="2.942"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.670"
ebitda="-49.36M"
eps_estimate_current_year="-2.250"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-2.500"
ex_dividend_date="N/A"
float_shares="10019000"
high="3.498"
high_52_weeks="5.490"
last_trade_date="1/13/2017"
last_trade_price="2.942"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.747"
low_52_weeks="1.804"
market_capitalization="69.37M"
moving_average_200_day="3.682"
moving_average_50_day="2.887"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.000"
open="2.920"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-20.090%"
percent_change_from_50_day_moving_average="+1.909%"
percent_change_from_52_week_high="-46.412%"
percent_change_from_52_week_low="+63.091%"
previous_close="2.820"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="22.315"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.190"
stock_exchange="NGM"
symbol="ONS"
volume="152103"
weeks_range_52="1.804 - 5.490"
